LCM
ANTX icon

Landscape Capital Management’s AN2 Therapeutics ANTX Stock Holding History

Landscape Capital Management’s Portfolio ANTX Stock Details ANTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$810K Sell
167,446
-130,720
-44% -$562K 0.05% 427
2026
Q1 		$1.02M Sell
298,166
-133,594
-31% -$276K 0.06% 385
2025
Q4 		$492K Sell
431,760
-24,703
-5% -$28.9K 0.03% 487
2025
Q3 		$580K Sell
456,463
-38,933
-8% -$44.5K 0.04% 438
2025
Q2 		$525K Buy
+495,396
New +$590K 0.04% 446

Other funds holding ANTX

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Landscape Capital Management's ANTX Position: Q2 2026 in Review

Landscape Capital Management reduced its AN2 Therapeutics (ANTX) stake by 44% in Q2 2026, selling an estimated $562K and leaving 167,446 shares worth $810K. The position accounts for 0.05% of the portfolio, ranked #427.

Landscape Capital Management first reported a position in ANTX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.02M in Q1 2026. 66 funds tracked by Wall St. Rank hold ANTX as of Q2 2026.

  • Landscape Capital Management held 167,446 shares of AN2 Therapeutics worth $810K as of Q2 2026.
  • Landscape Capital Management sold 130,720 AN2 Therapeutics shares in Q2 2026, an estimated $562K.
  • AN2 Therapeutics made up 0.05% of Landscape Capital Management's portfolio in Q2 2026, its #427 holding.
  • Landscape Capital Management first reported a position in AN2 Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Landscape Capital Management's AN2 Therapeutics position peaked at $1.02M in Q1 2026.
  • 66 funds tracked by Wall St. Rank held AN2 Therapeutics as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.